Global and United States Neoantigen Targeted Therapies Market Report & Forecast 2023-2028

Report ID: 1822683 | Published Date: Jan 2025 | No. of Page: 90 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Neoantigen Targeted Therapies Revenue in Neoantigen Targeted Therapies Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Neoantigen Targeted Therapies Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Neoantigen Targeted Therapies Market Size for the Year 2017-2028
        1.2.2 Global Neoantigen Targeted Therapies Market Size for the Year 2017-2028
    1.3 Neoantigen Targeted Therapies Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Neoantigen Targeted Therapies in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Neoantigen Targeted Therapies Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Neoantigen Targeted Therapies Market Dynamics
        1.4.1 Neoantigen Targeted Therapies Industry Trends
        1.4.2 Neoantigen Targeted Therapies Market Drivers
        1.4.3 Neoantigen Targeted Therapies Market Challenges
        1.4.4 Neoantigen Targeted Therapies Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Neoantigen Targeted Therapies by Type
    2.1 Neoantigen Targeted Therapies Market Segment by Type
        2.1.1 Monotherapy
        2.1.2 Combination Therapy
    2.2 Global Neoantigen Targeted Therapies Market Size by Type (2017, 2022 & 2028)
    2.3 Global Neoantigen Targeted Therapies Market Size by Type (2017-2028)
    2.4 United States Neoantigen Targeted Therapies Market Size by Type (2017, 2022 & 2028)
    2.5 United States Neoantigen Targeted Therapies Market Size by Type (2017-2028)
3 Neoantigen Targeted Therapies by Application
    3.1 Neoantigen Targeted Therapies Market Segment by Application
        3.1.1 Medical Research Institution
        3.1.2 Hospital and Clinic
        3.1.3 Other
    3.2 Global Neoantigen Targeted Therapies Market Size by Application (2017, 2022 & 2028)
    3.3 Global Neoantigen Targeted Therapies Market Size by Application (2017-2028)
    3.4 United States Neoantigen Targeted Therapies Market Size by Application (2017, 2022 & 2028)
    3.5 United States Neoantigen Targeted Therapies Market Size by Application (2017-2028)
4 Global Neoantigen Targeted Therapies Competitor Landscape by Company
    4.1 Global Neoantigen Targeted Therapies Market Size by Company
        4.1.1 Top Global Neoantigen Targeted Therapies Companies Ranked by Revenue (2021)
        4.1.2 Global Neoantigen Targeted Therapies Revenue by Player (2017-2022)
    4.2 Global Neoantigen Targeted Therapies Concentration Ratio (CR)
        4.2.1 Neoantigen Targeted Therapies Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Neoantigen Targeted Therapies in 2021
        4.2.3 Global Neoantigen Targeted Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Neoantigen Targeted Therapies Headquarters, Revenue in Neoantigen Targeted Therapies Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Neoantigen Targeted Therapies Headquarters and Area Served
        4.3.2 Global Neoantigen Targeted Therapies Companies Revenue in Neoantigen Targeted Therapies Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Neoantigen Targeted Therapies Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Neoantigen Targeted Therapies Market Size by Company
        4.5.1 Top Neoantigen Targeted Therapies Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Neoantigen Targeted Therapies Revenue by Players (2020, 2021 & 2022)
5 Global Neoantigen Targeted Therapies Market Size by Region
    5.1 Global Neoantigen Targeted Therapies Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Neoantigen Targeted Therapies Market Size by Region (2017-2028)
        5.2.1 Global Neoantigen Targeted Therapies Market Size by Region: 2017-2022
        5.2.2 Global Neoantigen Targeted Therapies Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Neoantigen Targeted Therapies Market Size YoY Growth 2017-2028
        6.1.2 North America Neoantigen Targeted Therapies Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Neoantigen Targeted Therapies Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Neoantigen Targeted Therapies Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Neoantigen Targeted Therapies Market Size YoY Growth 2017-2028
        6.3.2 Europe Neoantigen Targeted Therapies Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Neoantigen Targeted Therapies Market Size YoY Growth 2017-2028
        6.4.2 Latin America Neoantigen Targeted Therapies Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Neoantigen Targeted Therapies Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Neoantigen Targeted Therapies Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Bavarian Nordic
        7.1.1 Bavarian Nordic Company Details
        7.1.2 Bavarian Nordic Business Overview
        7.1.3 Bavarian Nordic Neoantigen Targeted Therapies Introduction
        7.1.4 Bavarian Nordic Revenue in Neoantigen Targeted Therapies Business (2017-2022)
        7.1.5 Bavarian Nordic Recent Development
    7.2 Genocea Biosciences
        7.2.1 Genocea Biosciences Company Details
        7.2.2 Genocea Biosciences Business Overview
        7.2.3 Genocea Biosciences Neoantigen Targeted Therapies Introduction
        7.2.4 Genocea Biosciences Revenue in Neoantigen Targeted Therapies Business (2017-2022)
        7.2.5 Genocea Biosciences Recent Development
    7.3 Gradalis
        7.3.1 Gradalis Company Details
        7.3.2 Gradalis Business Overview
        7.3.3 Gradalis Neoantigen Targeted Therapies Introduction
        7.3.4 Gradalis Revenue in Neoantigen Targeted Therapies Business (2017-2022)
        7.3.5 Gradalis Recent Development
    7.4 Immunicum
        7.4.1 Immunicum Company Details
        7.4.2 Immunicum Business Overview
        7.4.3 Immunicum Neoantigen Targeted Therapies Introduction
        7.4.4 Immunicum Revenue in Neoantigen Targeted Therapies Business (2017-2022)
        7.4.5 Immunicum Recent Development
    7.5 Immunovative Therapies
        7.5.1 Immunovative Therapies Company Details
        7.5.2 Immunovative Therapies Business Overview
        7.5.3 Immunovative Therapies Neoantigen Targeted Therapies Introduction
        7.5.4 Immunovative Therapies Revenue in Neoantigen Targeted Therapies Business (2017-2022)
        7.5.5 Immunovative Therapies Recent Development
    7.6 Iovance Biotherapeutics
        7.6.1 Iovance Biotherapeutics Company Details
        7.6.2 Iovance Biotherapeutics Business Overview
        7.6.3 Iovance Biotherapeutics Neoantigen Targeted Therapies Introduction
        7.6.4 Iovance Biotherapeutics Revenue in Neoantigen Targeted Therapies Business (2017-2022)
        7.6.5 Iovance Biotherapeutics Recent Development
    7.7 MediGene
        7.7.1 MediGene Company Details
        7.7.2 MediGene Business Overview
        7.7.3 MediGene Neoantigen Targeted Therapies Introduction
        7.7.4 MediGene Revenue in Neoantigen Targeted Therapies Business (2017-2022)
        7.7.5 MediGene Recent Development
    7.8 Neon Therapeutics
        7.8.1 Neon Therapeutics Company Details
        7.8.2 Neon Therapeutics Business Overview
        7.8.3 Neon Therapeutics Neoantigen Targeted Therapies Introduction
        7.8.4 Neon Therapeutics Revenue in Neoantigen Targeted Therapies Business (2017-2022)
        7.8.5 Neon Therapeutics Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Neoantigen Targeted Therapies Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Neoantigen Targeted Therapies Market Trends
    Table 3. Neoantigen Targeted Therapies Market Drivers
    Table 4. Neoantigen Targeted Therapies Market Challenges
    Table 5. Neoantigen Targeted Therapies Market Restraints
    Table 6. Global Neoantigen Targeted Therapies Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Neoantigen Targeted Therapies Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Neoantigen Targeted Therapies Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Neoantigen Targeted Therapies Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Neoantigen Targeted Therapies Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Neoantigen Targeted Therapies Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Neoantigen Targeted Therapies Revenue Share by Player, 2017-2022
    Table 13. Global Neoantigen Targeted Therapies Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Neoantigen Targeted Therapies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neoantigen Targeted Therapies as of 2021)
    Table 15. Top Players of Neoantigen Targeted Therapies in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Neoantigen Targeted Therapies Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Neoantigen Targeted Therapies Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Neoantigen Targeted Therapies Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Neoantigen Targeted Therapies Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Neoantigen Targeted Therapies Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Neoantigen Targeted Therapies Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Neoantigen Targeted Therapies Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Neoantigen Targeted Therapies Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Neoantigen Targeted Therapies Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Neoantigen Targeted Therapies Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Neoantigen Targeted Therapies Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Neoantigen Targeted Therapies Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Neoantigen Targeted Therapies Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Bavarian Nordic Company Details
    Table 31. Bavarian Nordic Business Overview
    Table 32. Bavarian Nordic Neoantigen Targeted Therapies Product
    Table 33. Bavarian Nordic Revenue in Neoantigen Targeted Therapies Business (2017-2022) & (US$ Million)
    Table 34. Bavarian Nordic Recent Development
    Table 35. Genocea Biosciences Company Details
    Table 36. Genocea Biosciences Business Overview
    Table 37. Genocea Biosciences Neoantigen Targeted Therapies Product
    Table 38. Genocea Biosciences Revenue in Neoantigen Targeted Therapies Business (2017-2022) & (US$ Million)
    Table 39. Genocea Biosciences Recent Development
    Table 40. Gradalis Company Details
    Table 41. Gradalis Business Overview
    Table 42. Gradalis Neoantigen Targeted Therapies Product
    Table 43. Gradalis Revenue in Neoantigen Targeted Therapies Business (2017-2022) & (US$ Million)
    Table 44. Gradalis Recent Development
    Table 45. Immunicum Company Details
    Table 46. Immunicum Business Overview
    Table 47. Immunicum Neoantigen Targeted Therapies Product
    Table 48. Immunicum Revenue in Neoantigen Targeted Therapies Business (2017-2022) & (US$ Million)
    Table 49. Immunicum Recent Development
    Table 50. Immunovative Therapies Company Details
    Table 51. Immunovative Therapies Business Overview
    Table 52. Immunovative Therapies Neoantigen Targeted Therapies Product
    Table 53. Immunovative Therapies Revenue in Neoantigen Targeted Therapies Business (2017-2022) & (US$ Million)
    Table 54. Immunovative Therapies Recent Development
    Table 55. Iovance Biotherapeutics Company Details
    Table 56. Iovance Biotherapeutics Business Overview
    Table 57. Iovance Biotherapeutics Neoantigen Targeted Therapies Product
    Table 58. Iovance Biotherapeutics Revenue in Neoantigen Targeted Therapies Business (2017-2022) & (US$ Million)
    Table 59. Iovance Biotherapeutics Recent Development
    Table 60. MediGene Company Details
    Table 61. MediGene Business Overview
    Table 62. MediGene Neoantigen Targeted Therapies Product
    Table 63. MediGene Revenue in Neoantigen Targeted Therapies Business (2017-2022) & (US$ Million)
    Table 64. MediGene Recent Development
    Table 65. Neon Therapeutics Company Details
    Table 66. Neon Therapeutics Business Overview
    Table 67. Neon Therapeutics Neoantigen Targeted Therapies Product
    Table 68. Neon Therapeutics Revenue in Neoantigen Targeted Therapies Business (2017-2022) & (US$ Million)
    Table 69. Neon Therapeutics Recent Development
    Table 70. Research Programs/Design for This Report
    Table 71. Key Data Information from Secondary Sources
    Table 72. Key Data Information from Primary Sources
List of Figures
    Figure 1. Neoantigen Targeted Therapies Product Picture
    Figure 2. Global Neoantigen Targeted Therapies Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Neoantigen Targeted Therapies Market Size 2017-2028 (US$ Million)
    Figure 4. United States Neoantigen Targeted Therapies Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Neoantigen Targeted Therapies Market Size 2017-2028 (US$ Million)
    Figure 6. United States Neoantigen Targeted Therapies Market Share in Global 2017-2028
    Figure 7. Neoantigen Targeted Therapies Report Years Considered
    Figure 8. Product Picture of Monotherapy
    Figure 9. Product Picture of Combination Therapy
    Figure 10. Global Neoantigen Targeted Therapies Market Share by Type in 2022 & 2028
    Figure 11. Global Neoantigen Targeted Therapies Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Neoantigen Targeted Therapies Market Share by Type (2017-2028)
    Figure 13. United States Neoantigen Targeted Therapies Market Share by Type in 2022 & 2028
    Figure 14. United States Neoantigen Targeted Therapies Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Neoantigen Targeted Therapies Market Share by Type (2017-2028)
    Figure 16. Product Picture of Medical Research Institution
    Figure 17. Product Picture of Hospital and Clinic
    Figure 18. Product Picture of Other
    Figure 19. Global Neoantigen Targeted Therapies Market Share by Application in 2022 & 2028
    Figure 20. Global Neoantigen Targeted Therapies Market Size by Application (2017-2028) & (US$ Million)
    Figure 21. Global Neoantigen Targeted Therapies Market Share by Application (2017-2028)
    Figure 22. United States Neoantigen Targeted Therapies Market Share by Application in 2022 & 2028
    Figure 23. United States Neoantigen Targeted Therapies Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. United States Neoantigen Targeted Therapies Market Share by Application (2017-2028)
    Figure 25. North America Neoantigen Targeted Therapies Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 26. U.S. Neoantigen Targeted Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Canada Neoantigen Targeted Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Europe Neoantigen Targeted Therapies Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. Germany Neoantigen Targeted Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. France Neoantigen Targeted Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. U.K. Neoantigen Targeted Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Italy Neoantigen Targeted Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Russia Neoantigen Targeted Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Neoantigen Targeted Therapies Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. China Neoantigen Targeted Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Japan Neoantigen Targeted Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. South Korea Neoantigen Targeted Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. India Neoantigen Targeted Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Australia Neoantigen Targeted Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Taiwan Neoantigen Targeted Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Indonesia Neoantigen Targeted Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Thailand Neoantigen Targeted Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Malaysia Neoantigen Targeted Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Philippines Neoantigen Targeted Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Latin America Neoantigen Targeted Therapies Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 46. Mexico Neoantigen Targeted Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Brazil Neoantigen Targeted Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Argentina Neoantigen Targeted Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Neoantigen Targeted Therapies Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Turkey Neoantigen Targeted Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Neoantigen Targeted Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. U.A.E Neoantigen Targeted Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Bavarian Nordic Revenue Growth Rate in Neoantigen Targeted Therapies Business (2017-2022)
    Figure 54. Genocea Biosciences Revenue Growth Rate in Neoantigen Targeted Therapies Business (2017-2022)
    Figure 55. Gradalis Revenue Growth Rate in Neoantigen Targeted Therapies Business (2017-2022)
    Figure 56. Immunicum Revenue Growth Rate in Neoantigen Targeted Therapies Business (2017-2022)
    Figure 57. Immunovative Therapies Revenue Growth Rate in Neoantigen Targeted Therapies Business (2017-2022)
    Figure 58. Iovance Biotherapeutics Revenue Growth Rate in Neoantigen Targeted Therapies Business (2017-2022)
    Figure 59. MediGene Revenue Growth Rate in Neoantigen Targeted Therapies Business (2017-2022)
    Figure 60. Neon Therapeutics Revenue Growth Rate in Neoantigen Targeted Therapies Business (2017-2022)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bavarian Nordic
Genocea Biosciences
Gradalis
Immunicum
Immunovative Therapies
Iovance Biotherapeutics
MediGene
Neon Therapeutics
Frequently Asked Questions
Neoantigen Targeted Therapies report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Neoantigen Targeted Therapies report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Neoantigen Targeted Therapies report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports